Guangzhou Hanfang Pharmaceutical Company Limited, founded in 1998 and headquartered in Guangzhou, China, is a global leader in high-end medicinal lipid excipients. We focus on providing domestically produced, globally compliant injectable soybean oil and agency partnership services for pharmaceutical manufacturers, distributors, and health product enterprises. With core technologies breaking international monopolies and certifications including EU CEP and US FDA US-DMF, we have served over 1,000 clients across 30+ countries, including AstraZeneca and B. Braun. Our mission is to achieve technological self-reliance, solve supply chain bottlenecks, and ensure pharmaceutical industry chain safety, offering stable, cost-effective alternatives to imported excipients.

Company Overview

- Full Company Name: Guangzhou Hanfang Pharmaceutical Company Limited
- Founded: 1998
- Global Headquarters: Guangzhou, China
- Global Coverage: Services across 30+ countries and regions
- Core Team: Led by national-level experts with State Council Special Allowance and "Ten Thousand Talents Program" honors, boasting over 20 years of pharmaceutical R&D experience

Product & Agency Services

Focusing on the core pain points of unstable imported supply, high costs, and compliance challenges for pharmaceutical distributors and manufacturers, we offer targeted agency programs:

Injectable Soybean Oil Agency Program
- Target Clients: Pharmaceutical distributors, injectable drug manufacturers, and health product enterprises
- Core Pain Points Solved: Reliance on imported excipients, supply chain disruptions, high procurement costs, complex compliance procedures
- Core Support: Stable domestic supply, global compliance certification assistance, customized marketing materials, technical training, 1-on-1 account management
- Client Value: Reduce procurement costs by up to 30%, cut supply chain risk by 40%, and access global markets quickly with certified products

We also offer agency programs for other high-end medicinal lipid products including egg yolk lecithin and medium-chain triglycerides to meet diverse client needs.

Core Advantages

1. Domestic Substitution Technology: Developed the first domestically produced injectable soybean oil, increasing domestic localization rate from 10% to 90% to ensure stable supply for partners
2. Global Compliance: Hold EU CEP, US FDA US-DMF, Mexico Cofepris, and India DCGI certifications, enabling seamless access to global markets
3. Proven Client Trust: Served over 1,000 clients including global pharmaceutical leaders like AstraZeneca and B. Braun, with products sold in 30+ countries
4. Comprehensive Support: Provide end-to-end agency support including marketing, training, and after-sales service to accelerate partner growth.

Client Cases

- AstraZeneca (Global Pharmaceutical Industry): Adopted Hanfang’s injectable soybean oil to stabilize raw material supply, reducing supply chain risks by 40%
- B. Braun Company (Global Medical Technology): Partnered with Hanfang for injectable excipient supply, cutting procurement costs by 25%
- Sichuan Kelun Pharmaceutical (Domestic Pharmaceutical Leader): Achieved domestic substitution with Hanfang’s injectable soybean oil, ensuring uninterrupted production.

Contact Us

- Official Website: https://byshanhanfang.com/
- Global Headquarters: 134 Jiangnan Avenue Middle, Haizhu District, Guangzhou, China
- Production Base: 8 Hot Spring Avenue, Conghua District, Guangzhou, China.